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Analysis of immune status of hemodialyzed adults: Association with
prior transfusions. Peripheral blood leukocytes of 29 hemodialyzed
adults, 19 transfused and 10 nontransfused, were studied using im-
munofluorescent staining with monoclonal antibodies and in vitro
measurement of natural killer (NK) cell activity. When compared with
control subjects, the absolute number of leukocytes in transfused
hemodialyzed patients was significantly reduced (P < 0.01), as were the
absolute numbers of OKTIL cells (P <0.01), and OKT4 cells (P <
0.0001). The percent representation of OKT11 and OKT4 cells was
also significantly lower among transfused hemodialyzed patients (P <
0.01 and 0.001, respectively), and this loss of 0KT4 cells resulted in
a decrease in the ratio of OKT4/OKT8 cells (P <0.01). The absolute
number of Leu-7 cells was also decreased in the transfused group (P
< 0.05). A decrease in in vitro NK cell activity was present in both
transfused and nontransfused hemodialyzed subjects. Whether these
differences in peripheral blood lymphocytes were induced by the
erythrocyte transfusions could not be determined: however, if they
reflect changes in central lymphoid tissues, then these results may help
explain the prolonged survival of renal allografts in transfused
individuals.
Analyse de l'état immunitaire des adultes hémodialysés: Relation avec
les transfusions antérleures. Les leucocytes sanguins périphériques de
29 adultes hémodialysés. dont 19 transfusés et lO non transfusés ont été
étudiés par marquage en immunofluorescence avec des anticorps
monoclonaux et mesure in vitro de l'activité cellulaire killer naturelle
(NK). Par rapport a des sujets contrOles. Ic nombre absolu de
leucocytes chez les hemodialysés Iransfusés était significalivement
moindre (P <0,01), de méme que le nombre absolu de cellules OKTI I
(P <0,01) et OKT4 (P <0,0001). Le pourcentage de cellules OKTI I
et OKT4 était egalement plus faible chez les hémodialysés transfusés
(P < 0,01 et 0.001, respectivement), et cette perte de cellules 0KT4
entrainait une diminution du rapport des cellules OKT4 /OKT8 (P <
0,01). Le nombre absolu de cellules Leu-7 était egalement diminué
dans le groupe transfuse (P < 0,05). Une baisse de l'activitC cellulaire
NK in vitro était présente chez les hémodialysés transfusés ou non. Ii
na pu Ctre déterminC si ces differences dans les lymphocytes sanguins
pCriphCriques étaient dues aux transfusions erythrocytaires; cependant,
si elks reflètent des modifications des tissus lymphoides centraux. ces
rCsultats peuvent alors aider a comprendre La survie prolongee des
allogreffes rénales chez les sujets transfusés.
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Multiple alterations in immune function occur in nondialyzed
persons with chronic uremia [1—31, as well as those maintained
on chronic hemodialysis [41. Azotemic individuals have
lymphopenia [5, 61 with absolute decreases in both B- and
T-lymphocytes [7, 8]. Functional lymphocyte abnormalities are
also seen: Uremic patients have impaired cutaneous hyper-
sensitivity [9, 101, prolonged survival of skin allografts [11], and
depressed antibody production [10]. In vitro lymphocyte assays
demonstrate reduced proliferative responses to T and B cell
mitogens [7, 101, and allogenic cells [12], and variable effects on
cytotoxicity [13—15]. Recently, using monoclonal antibodies,
the T-cell subsets in the peripheral blood of hemodialyzed
uremic patients have been examined. These studies revealed a
normal percent representation [15—18] but decreased absolute
numbers of OKT3 and OKT4 cells [15, 16].
The pathogenesis of these changes remains obscure although
the immunosuppressive effects of uremic sera [4, 9, 13] and
changes induced by the hemodialysis membrane [4] are recog-
nized. A recent study has linked long-term hemodialysis with
alterations in absolute numbers of OKT3 and OKT4 cells
[16]. However, this study did not consider the possible effects
of blood transfusions, a subject of special interest since multiple
transfusions are known to be associated with prolonged renal
allograft survival [191. In this study we have evaluated periph-
eral blood lymphocyte (PBL) subpopulations of transfused and
nontransfused patients on chronic maintenance hemodialysis
with monoclonal antibodies and an in vitro assay of natural
killer (NK) cell activity.
Methods
Patient population. Twenty-nine subjects (19 men, 10
women: mean age 47.4 years: range, 27 to 68 years) on chronic
maintenance hemodialysis were studied at least 24 hr after their
last dialysis treatment. Patients were dialyzed three times each
week in 5-hr sessions using cuprophane flat-plate dialyzers
(Gambro, Lund, Sweden). Their renal function was greatly
impaired as indicated by serum creatinine (mean, 16.6 mg/dl;
range, 9.3 to 24.8 mg/dl) and BUN (mean, 73.4 mg/dl; range, 31
to 118 mg/dl). The mean duration of dialysis was 51.5 months
(1.5 to 156 months). The etiologies of the renal failure were
hypertensive nephropathy (11 patients), chronic glomerulo-
nephritis (8). heroin-associated nephropathy (3), chronic inter-
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stitial nephritis (1), obstructive nephropathy (1). and unknown
(5). Nineteen hemodialysis patients had received frozen
leukocyte-poor red blood cell transfusions while ten had not. Of
those patients receiving transfusions, one patient had received
4 U while the rest had received 9 U or more. No patient was
receiving any drug known to have an effect on lymphocyte
number or function. Although no formal assessment of nutri-
tional status was performed, all patients had normal serum
albumin levels.
Isolation of mononuclear cells. Heparinized peripheral blood
(10 to 20 ml) was diluted 1:2 with RPMI 1640 (GIBCO, Grand
Island, New York) and separated by differential bouyancy
centrifugation on Ficoll/sodium diatrizoate (LSM, Litton
Bionetics, Kensington, Maryland). Interface cells were aspi-
rated with a pipet (Pasteur), washed twice in RPMI 1640 and
counted in a hemocytometer. This mononuclear cell prepara-
tion was adjusted to 10 >< 106 cells/mI in complete medium
consisting of RMPI 1640 supplemented with 10% fetal bovine
serum (lot #100405, FCS, Hyclone, Logan, Utah) and 20 m
N-2-hydroxyethyl-piperazine-N '-2 ethanesulfonic acid
(HEPES).
Cytotoxicity assay. Cultured cells from the K562 human
erythroleukemic cell line (provided by Dr. R. B. Herberman,
National Cancer Institute, National Institutes of Health,
Bethesda, Maryland), grown in Dulbecco's Modified Eagle
Medium supplemented with 10% FCS, 1 m Na pyruvate, 5 x
l0— M 2-mercaptoethanol and 100 g/ml gentamicin were used
as target cells. The line was mycoplasma free and routinely
subcultured the day before use in an assay. For radioactive
isotope labelling of target cells, 2 x 106 K562 cells suspended in
0.15 ml TRIS buffer, pH 7.4, were incubated with occasional
mixing with 0.2 1LCi Na2 51CrO4 in 0.2 ml of sterile isotonic
sodium chloride solution (ICN, Irvine, California; spec act 50 to
500 Ci/g chromium) at 37°C for 30 mm. The 51Cr-labelled K562
cells were then twice centrifuged through 2 ml of heat in-
activated FCS to remove unincorporated 5tCr. After adjustment
to a density of I x l0 cell/mI in complete medium, 100 1d (l0
radiolabelled target cells) were added to each well in a round-
bottom microtiter plate, (LINBRO Chemical. New Haven,
Connecticut) containing 100 pA of serially diluted effector cells.
Seven effector to target ratios from 100: 1 to 1.56:1 were used
and each ratio was run in duplicate. Following the addition of
the target cells, the microtiter plate was centrifuged at >< 400g
for 4 mm, then incubated at 37°C in a humidified atmosphere
containing 5% CO2. After a 4-hr incubation, 100 pA of super-
natant were carefully removed from each well and placed into
individual 12 x 75 mm glass tubes. The level of released
radioactivity was determined in a gamma counter (Nuclear
Chicago, Des Plaines, Illinois). Specific lysis was calculated
from the 51Cr release in counts per minute (cpm) using the
formula:
% of release = Experimental cpm — spontaneous cpm
Maximum release cpm — spontaneous cpm
Spontaneous and maximum release cpm were determined by
incubating I x IO 51Cr-radiolabelled K562 cells with either 100
pA complete media or 1.9 ml distilled water, respectively. The
mean spontaneous 51Cr release by the K562 target cells in the
absence of effector cells was 7.2 0.9%.
Dose-response curves were determined for each individual
by plotting the percent specific 51Cr release obtained at each of
the seven effector:target ratios versus the log0 of the number of
effector cells. The level of NK cell activity of PBL from a
healthy volunteer was determined for each assay performed.
Eff'ct of uremic sera on NK activity. In these experiments,
uremic sera from eight donors with both normal and abnormal
PBL NK activity were studied. Specific 5Cr release was
determined as described above, except that the complete me-
dium consisted of RPMI 1640, 20 mrvi HEPES and 10% heat-
inactivated (56°C for 30 mm) uremic sera. Lymphocytes from
two healthy donors were used as effector cells. Heat-
inactivated autologous sera were used in the control experi-
ments.
Analysis by flow cvtometry. Lymphocyte subclasses were
enumerated using the previously described method of Hoffman
et al [20]. Briefly, whole blood samples (50 pA) were stained with
10 tsl of fluorescein conjugated OKT3 (Pan T cell), OKT4
(helper/inducer), OKT8 (suppressor/cytotoxic), or the OKT1 1
(sheep erythrocyte receptor) monoclonal antibodies (Ortho
Diagnostic Systems, Raritan, New Jersey) [21, 221. After a
30-mm incubation at 4°C, the whole blood samples were treated
with 2 ml of NH4CI-EDTA lysing buffer for 5 mm at room
temperature and were immediately analyzed on a
Cytofluorograf System 50H (Ortho Instruments, Westwood,
Massachusetts) equipped with an argon ion laser (Model 95,
Lexel), which was operated at a wavelength of 488 nm and
maintained at 250 mw voltage. Prior to cellular analysis the
instrument was standardized using a l0- diameter, half bright,
green fluorospheres (Lot #3425, Coulter Electronics, Inc.,
Hialeah. Florida). Using the forward and right angle scatter
measurements, the lymphocyte population was selected and the
percentage of green fluorescent cells was determined. Three
subjects also had their T-lymphocyte subpopulations enumer-
ated simultaneously using Ficoll/Hypaque separated mono-
nuclear cells. To examine the percentage of cells with surface
immunoglobulin (sIg) I >< 106 Ficoll/Hypaque separated
mononuclear cells were stained with fluorescein conjugated
F(ab)2 goat anti-human Ig (Cappel Labs, Inc., Cochranville,
Pennsylvania). NK cells were enumerated by staining mono-
nuclear cells with 5 pA of fluorescein conjugated anti-Leu-7
monoclonal antibody (HNK-1) (Becton Dickinson, Mountain
View, California). After 30 mm at 4°C, the cells were washed
with phosphate-buffered saline (PBS) and resuspended in 1.0 ml
of cold PBS. A total of at least 10,000 lymphocytes were
analyzed with each antibody. The total white cell count was
obtained using a Coulter Counter (Coulter Electronics, Inc.,
Hialeah, Florida) and the percent lymphocytes determined by
morphologic criteria using May-Giemsa stained blood films.
Absolute numbers of peripheral blood cells reactive with each
of the inonoclonal antibodies were calculated as the product of
the total white cell count, percent lymphocytes, and the percent
positive cells determined by flow cytometry. Control data were
obtained from Baltimore Longitudinal Study of Aging volun-
teers [231.
Statistical analysis. The Wilcoxon rank sum test was used for
comparison of mean values. Stepwise linear regression analysis
by forward selection with pair switching was used for multiple
regression analysis. The paired t test was also used where
indicated in the text.
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Table 1. Immune parameters in hemodialyzed adults and healthy controls
Controls
Hemodialyzed subjects
Total Transfused Nontransfused
Leukocyteslmm3 6555 228k 5994 646C 5386 576 7187 1505
Lymphocytes, % 29.7 1.6 30.5 2.2 28.9 3.3 33.5 1.8
Im,n3 1898 108 1761 191 1461 172 2331 401
OKT3, % 69.1 1.6 62.9 2.1" 64.2 2.6 60.5 3.7"
1mm3 1323 86 1096 123 918 118C 1433 255
OKT4, % 48.1 1.1 38.7 2.5c 35•5 32d 44.7 3.3
1mm3 924 64 692 100" 486 60C 1082 225
OKT8, % 26.4 1.0 29.7 2.1 30.9 2.7 27.5 3.1
1mm3 506 36 530 70 483 96 619 88
OKT1l, % 71.0 1.7 63.5 16d 63.6 2.2" 63.3 2.4"
1mm3 1363 98 1113 122" 927 117" 1467 247
LEU-7, % 10.2 1.3 10.9 1.3 10.5 1.7 11.8 1.7
1mm3 225 35 198 31 160 3.8" 271 98
sIg, %
1mm3
21.1 1.0
413 30
25.8
460
2.l1
65"
26.9 3.0
389 58
23.7 1.8
596 147
OKT4IOKT8 1.98 0.10 1.5 1 0.16 1.35 0.20" 1.87 0.27
a Mean SEM.
P < 0.05 as compared to control subjects.
P < 0.01 as compared to control subjects.
d P < 0.001 as compared to control subjects.
P < 0.0001 as compared to control subjects.
Results
Peripheral blood lymphocyte suhpopulations
The T-cell, NK-cell, and B-cell lymphocyte populations
present in the peripheral blood of 29 hemodialysis subjects were
examined using the OKT3, OKT4, OKT8, OKTI 1. and Leu-7
monoclonal antibodies and a goat anti-human IgG antibody.
The results as shown in Table I demonstrate that despite a
decrease in the peripheral blood leukocyte count, among
hemodialyzed subjects, there is no difference in the absolute
lymphocyte counts.
The proportion of total peripheral blood T-lymphocytes
(OKT3, OKTl1) and helper/inducer T-cells (OKT4) was
significantly decreased in the uremic population while the
representation of suppressor/cytotoxic T-cells (OKT8 ) was
slightly increased. As a consequence of these changes, the ratio
of OKT4/OKT8 cells was also decreased, but was not
statistically significant. The percentage of sIg cells was sig-
nificantly increased in the hemodialyzed population. The per-
centage of NK cells (Leu-7) was not different from the levels
found in the control population.
When absolute numbers of each subpopulation were deter-
mined, a statistically significant decrease was seen in the
OKT11 and OKT4 subsets, while a significant increase was
found in sIg cell population.
T-lymphocyte suhpopulations in three subjects were enumer-
ated simultaneously with the use of whole blood samples and
Ficoll/Hypaque separated mononuclear cells. The values so
determined were within 3% (data not shown).
LjJect of red blood cell transfusions
Because many patients on chronic hemodialysis receive
blood transfusions, it was of interest to determine the effects of
blood transfusion on lymphocyte subsets and NK cells.
As seen in Table 1, the changes in PBL subpopulations of
hemodialyzed subjects occur almost exclusively in the group
who received erythrocyte transfusions. Compared to controls,
the transfused group had a statistically significant decrease in
total peripheral leukocyte count. The percentage and absolute
numbers of cell bearing total T-lymphocyte surface markers
(OKT3, OKT1l) were also decreased. The most obvious
change occurred in the helper/inducer (OKT4) T-lymphocyte
subset with large decreases in both the absolute number and
percent representation of these cells, which resulted in a
significant decrease in the OKT4/OKT8 ratio, despite no
change in the suppressor/cytotoxic (OKT8 ) subpopulation.
This is depicted in Figure 1 for the OKT4/OKT8 ratio. While
there were slight increases in the percentage of Leu-7 and
sIg cells, there were decreases in the absolute number of these
cells, but this difference reached statistical significance only for
the absolute number of Leu-7' cells.
In contrast to these findings, the only statistically significant
differences between the nontransfused hemodialyzed subjects
and control subjects were seen in the percentages of T-
lymphocytes (OKT3, OKTI l) which were decreased as in
the transfused group. No effect of transfusion was seen on
N K-cell activity.
NK—cell activity
Since the proportion of Leu-7 cells was different between
the control and dialyzed populations, the functional levels of
NK activity were investigated. The levels of NK activity at a
5:1 effector:target ratio in the dialyzed group were widely
distributed (range, 0 to 70%). Mean NK activity of the group
was 24.9 3.8% which was significantly lower than the control
group (39.6 4.0%; P < 0.05). There was no difference
between the NK activities of transfused and nontransfused
hemodialyzed individuals (25.9 4.6%, 23.7 7.4%, respec-
tively). There was no effect of age or gender on NK cell
activity. It is important to note that repeat determinations of
NK activity from 12 individuals (9 to 12; mean, 10.6 months
later) showed no statistically significant correlation by paired
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Fig. 1. The OKT4/OKT8 ratio. The mean value of the ratio is
significantly lower and the values are more widely distributed for the
transfused group as compared to the control group.
test. Six hemodialyzed individuals had markedly low NK
activity(< 10%). Two individuals who had very low NK activity
(4% 51Cr release) demonstrated 34 and 38% release on repeat
analysis, while two other individuals with 29 and 34% release
had only 1% release each on retesting.
Effect of uremic sera on levels of normal NK effector
cell function
To test the effects of uremic sera on NK cell function,
experiments were carried out in which NK assays were run in
the presence of sera from normal individuals or uremic patients.
It was found that in normal subjects the presence of uremic sera
decreased NK activity against K562 target cells by 60.8 4.9%
(mean sEM). There was no difference in the amount of
suppression between sera from uremic donors with normal or
abnormal NK activity. Although the number of individual sera
tested was small, there was a 49.2 3.3% decrease in NK
activity in the presence of sera from four nontransfused patients
versus 69.5 7.3% decrease with sera from four transfused
patients (P> 0.10).
Effect of gender and age. There were no differences in PBL
subpopulations found between hemodialyzed men and women.
Compared to control women, hemodialyzed women had a
statistically significant decrease in their total leukocyte count
(4913 559/mm3), percent of OKTI I + (63.2 2.2%), absolute
number of OKT1 I + cells (958 162/mm3), and percentage of
Hemodialyzed Controls P
Leukocytes 6383 I l46/mm3a 6574 309/mm3 NS
Lymphocytes 28.6 1.9%
1773 318/mm3
32.8 2.0%
2076 124/mm3
NS
<0.05
OKT3 62.5 3.1%
1104 198/mm3
70.0 1.7%
1473 105/mm3
<0.05
<0.05
OKT4* 41.0 1.9%
738 154/mm3
48.6 1.4%
1013 74/mm3
<0.01
<0.01
OKT8 29.1 8.4%
543 125/mm3
26.8 1.2%
563 42/mm3
NS
NS
OKTI1 65.2 2.1%
1151 198/mm3
71.8 1.8%
1545 101/mm3
<0.01
<0.01
LEU-7 11.5 1.5%
209 47/mm3
9.3 1.1%
231 38/mm3
NS
NS
slg 29.9 2.9%
520 106/mm3
21.3 1.3%
462 38/mm3
<0.05
NS
OKT4/OKT8 1.72 0.24 1.94 0.12 NS
sIg cells (29.3 3.4%). Compared to control men,
hemodialyzed men had a significant decrease in their percent-
age of OKT4 cells (38.2 2.7%) and percentage of OKTll
cells (63.6 2.2%). Due to this decrease in OKT4 cells and a
significant increase in OKT8 cells (31.4 2.7%), the ratio of
OKT4/OKT8 cells (1.47 0.19) was also significantly
reduced.
Since PBL subpopulations vary with age in normal popula-
tions [231, the effect of age on PBL in hemodialyzed adults was
examined. If the individuals tested were divided by their mean
age into young (<47 years) or old (>47 years) groups, no
difference was seen between the two groups. However, as
shown in Table 2, several differences were observed in the PBL
between young hemodialyzed subjects and young control sub-
jects. Because of a slight decrease in their total peripheral
leukocyte count and percentage of lymphocytes, a significant
decrease in the absolute lymphocyte count of young
hemodialyzed adults was found. Additionally, a significant
decrease was seen in both the percentage and absolute numbers
of PBL reactive with OKT3 or OKTI 1 monoclonal antibodies.
A decrease was also seen in the absolute numbers and percent-
ages of the helper/inducer (OK4) subset, while no changes
were observed in the suppressor/cytotoxic (OKT8) subset nor
in the ratio of OKT4/OKT8 cells. An increase was found in
the percentage of sIg cells in the young hemodialyzed popula-
tion, but no statistically significant change was found in the
absolute numbers of these cells. No differences were observed
between older hemodialyzed subjects and older control subjects
except for a decreased total peripheral leukocyte count (5631
676/mm3) and ratio of OKT4/OKT84 cells (1.38 0.22).
Influence of duration of dialysis. Because of the wide varia-
tions seen in PBL subpopulations, it was interesting to examine
the long-term effects of hemodialysis. Those individuals receiv-
ing hemodialysis for less than 2 years had no significant
differences in their lymphocyte subsets when compared with
the control population (Table 3). Subjects receiving
hemodialysis for greater than 2 years showed several marked
differences versus the control population. Decreases were seen
in the total peripheral leukocyte count, the percentages and
5.0
1.0
0.5
Table 2. Peripheral blood lymphocyte populations in young
individuals
0
aDI-
0
0
a
0
aD
I.
—F-'
a.
= Mean SEM
Abbreviation: NS, not significant.
a Mean SEM.
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Table 3. Influence of duration of dialysis on peripheral blood lymphocytes
P"
Time on dialysis
Less than 2 years p' Greater than 2 years PC
Leukocytes NSd 8530 1548/rnrn3e <0.05 4659 272/mm3 <0.0001
Lymphocytes NS
NS
25.1 3.4%
2170 470/mm3
NS
NS
33.4 2.8%
1545 145/mm3
NS
NS
OKT3 NS
NS
66.3 2.9%
1405 292/mm3
NS
NS
61.1 2.8%
933 96/mm3
<0.05
<0.05
OKT4 NS
NS
44.7 4.4%
996 247/mm3
NS
NS
35.5 2.9%
532 59/mm3
<0.0001
<0.001
OKT8 NS
NS
34.0 4.3%
710 154/mm
NS
NS
27.5 2.1%
435 56/mm3
NS
NS
OKTl1 NS
NS
'68.3 2.3%
1449 292/mm3
<0.05
NS
61.0 2.0%
936 83/mm3
<0.0001
<0.01
LEU-7 NS
NS
13.4 2.5%
285 71/mm3
NS
NS
9.6 1.4%
152 25/mm3
NS
NS
sIg NS
NS
25.4 2.5%
579 154/mm3
NS
NS
26.0 2.9%
398 56/tom3
NS
NS
OKT4/OKT8 NS 1.55 0.24 NS 1.54 0.22 <0.05
a The time was less than 2 years versus the control population.
The time was less than 2 years versus the time greater than 2 years.
The time was greater than 2 years versus the control population.
d NS is not significant.
Mean SEM.
absolute numbers of both total T-lymphocytes (OKT3,
OKT114'), and helper/inducer (OKT4) cells. A significant
decrease was also seen in the ratio of OKT4/OKT8 cells.
As a corollary to these observations, the monoclonal anti-
body determinations of PBL were repeated on 13 subjects
separated by a 9- to 12-month interval (mean, 10.6). Although
the mean values were not different, there was no statistically
significant correlations between the two observations in many
of the PBL subsets examined when the paired t test was used.
This lack of correlation was present in both transfused and
nontransfused individuals.
Multiple regression analysis. Since blood transfusion, age,
gender, and the duration of dialysis may affect parameters
studied, multiple regression analysis was used to examine the
interactions of these variables. Except for a decrease in the
absolute number of slg cells in younger individuals, only
blood transfusion and duration of dialysis had independent
effects on the other parameters studied. A significant correla-
tion was found between a decrease in the absolute lymphocyte
count, the absolute number of total T-cells (OKT3, OKTII ),
percent representation of OKT4 cells (all P < 0.05), absolute
number of OKT4 cells (P < 0.005), and blood transfusion. A
decrease in the total peripheral leukocyte count, percent of total
lymphocytes, percent representation and absolute numbers of
OKT4 cells, and peripheral blood NK cell activity were all
correlated with the number of months on dialysis (I' < 0.005).
Discussion
We have demonstrated through the use of monoclonal anti-
bodies (OKT3, OKTI I) reactive with I-cell surface markers
that the percentage and the absolute numbers of peripheral
blood T-lymphocytes are decreased in hemodialyzed adults.
Previous studies [7, 8] relying on assays utilizing sheep red
blood cell (SRBC) rosetting techniques have shown decreases
in absolute numbers but not proportions of T-lymphocytes.
While cells spontaneously forming rosettes with SRBC (E) are
classically accepted as T-lymphocytes, more recent evidence
indicates that T-lymphocytes are heterogenous and may have
several cell surface antigens [24]. Additionally, using mono-
clonal antibodies, 10 to 20% of E cells can be identified as
small 1a monocytes [25, 261. Two previous studies of uremic
patients on hemodialysis demonstrated a normal percentage of
PBL reactive with the monoclonal antibody OKT3 [17, 18], but
the absolute numbers of these cells were not reported. In two
other prior studies in which the absolute number of OKT3
cells were examined, they were also found to be decreased [15,
16].
The decreased representation of peripheral T-cells in the
present investigation seems to be accounted for by a decrease in
both the percentage and absolute number of PBL reactive with
the OKT4 monoclonal antibody. The number of lymphocytes
reactive with the OKT8 monoclonal antibody (suppres-
sor/cytotoxic cells) was slightly, but not statistically, increased.
Because of the decrease in OKT4 cells, the mean ratio of
OKT4/OKT8 cells was decreased.
The T-lymphocyte subset of helper/inducer cells, defined by
the monoclonal antibody OKT4, plays a central role in the
body's immune system. Its presence is required for maximum
in vitro proliferative responses to mitogens and antigens, as
well as some forms of cytotoxic T-cell activity [27]. Decreases
in the representation of OKT4 cells, which result in a lowered
ratio of OKT4/OKT8 cells, have been recently associated
with a variety of immunodeficiency states in which an increased
incidence of infections and tumors are prominent clinical fea-
tures [28, 291. The loss of peripheral blood OKT4 cells by
hemodialyzed patients may be part of the explanation for their
increased susceptibility to certain fungal, viral, and bacterial
infections [30—32] and various neoplasms [33, 34.
A previous study of hemodialyzed patients demonstrated a
decrease in the absolute numbers of OKT3 and OKT4 cells
associated with dialysis for more than 1 year [16]. A variable
effect of age was also seen. Neither of the prior studies, which
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demonstrated decreased absolute numbers of these cells, re-
ported the transfusion status of the subjects 115, 161. In our
study, using multiple regression analysis, age was found to be a
significant independent variable only in the percent representa-
tion of sIg cells. However, we did find a significant negative
correlation between duration of dialysis and total peripheral
leukocyte count, percent of PBL, percent representation and
absolute number of helper/inducer cells, and peripheral blood
NK-ceIl activity.
The most striking contrasts were found in those individuals
who had received blood transfusions. The transfused dialyzed
patients, compared to controls, had decreased absolute lym-
phocyte counts, absolute number of peripheral blood T-
lymphocyte (OKT3, OKTll), and helper/inducer (OKT4)
cells. These differences were still significant when multiple
regression analysis was performed. Previous studies of the
effects of transfusions on hemodialyzed individuals have con-
centrated on changes in the suppressor/cytotoxic (OKT8)
subset or the OKT4/OKT8 ratio. These have also demon-
strated a lower percentage of PBL reactive with OKT8 in
nontransfused uremic subjects [35, 36], but with normal OKT8
values in those who have received blood transfusions [36].
Contrary to these reports, we found a normal percentage and
number of OKT8 cells in nontransfused and transfused uremic
individuals. The decrease we noted in the OKT4/OKT8 ratio
was also not seen in a previous report [37], possibly due to the
fact that our controls were age-matched, and a slight decrease
in OKT8 cells and OKT4/OKT8 ratio occurs with in-
creased age [23]. It is possible that in these other reports this
variable was not considered. Another possibility is that these
other investigators used different methodologies for enumerat-
ing the number of suppressor cells. These include estimating the
number of suppressor cells by a rosette technique [351, intro-
ducing an additional variable by the use of either fluorescence
microscopy or laser flow cytometry in the same study [36], and
the use of monoclonal antibodies supplied by a different manu-
facturer [37]. It has also been reported that most changes in T
lymphocyte subsets occur in individuals who receive more than
five transfusions [36]. All, except one, of our patients received
nine or more transfusions. The one exception received four
transfusions and had a WBC of 7900/mm3 with 18% lympho-
cytes and 73% OKT3, 47% OKT4, and 21% OKT8 cells.
The correlation between pretransplantation red blood cell
transfusion and improved renal allograft survival is well estab-
lished, although the mechanism remains obscure [19, 36,
38—40]. In various studies on this subject, transfused individuals
have been shown to have an increased percentage of suppressor
cells, increased suppressor cell activity [36], enhanced induc-
tion of lymphocytotoxic antibodies [37], depressed cell-
mediated immunity as measured by dinitrochlorobenzene skin
reactivity [40], and decreased mixed lymphocyte reactions [41].
No changes in in vitro proliferative responses to mitogens have
been reported [42]. Several studies have shown that an increase
in T-lymphocytes as measured by SRBC rosettes [43, 44] or the
monoclonal antibody OKT3 [17] is correlated with renal al-
lograft rejection, while depleting circulating T-lymphocytes
prolongs allograft survival [17]. In the present study, the largest
change was seen in the OKT4 subpopulation. Because of the
importance of this helper/inducer subpopulation in the resist-
ance to renal allografts, it is carefully monitored in transplant
recipients [17]. If the decreased number of peripheral OKT4
cells reflect changes in central lymphoid tissues, this may help
explain the decreased resistance of transfused individuals to
transplanted allografts.
Whether the differences in PBL populations observed in
patients who received red blood cell transfusions were a result
of these transfusions or are present because of a generalized
hypofunction of the bone marrow is not known. However, as
demonstrated in Figure 1 the values of the OKT4/OKT8
ratio in the transfused, hemodialyzed subjects are widely dis-
tributed, which may imply that only certain individuals are
prone to develop changes in PBL or that a hypothetical
lymphocytoxic agent is present in only certain units of blood.
Cytomegalovirus (CMV) is one such possible agent that has
been implicated in transfusion-transmitted infections [45], but it
is unlikely that CMV is the putative agent in our subjects.
Acquired CMV infection is usually associated with a
lymphocytosis and although there is a decrease in the
OKT4/OKT8 ratio, this change is caused by an increase in
the OKT8 subset [46, 47], not a decrease in the OKT4 subset
as seen in our patients. A prospective study of the effect of red
cell transfusions in uremic subjects is currently underway to
help determine the mechanism of these changes in PBL sub-
populations.
When patients were restudied after 1 year, we noted the
following: First, the differences between transfused and
nontransfused patients were still apparent. Second, the mean
values for any given immune parameter did not change signifi-
cantly for either transfused or nontransfused patients. Finally,
within groups individuals demonstrated a marked variation.
There was no correlation with etiology of renal failure, medica-
tions, or change in clinical status. It would seem that since the
PBL populations in these patients change markedly over time,
studies of small numbers of patients with only one sampling
time would be less reliable in outlining the pathophysiology of
this patient population.
Currently, there is a paucity of reported serial studies on PBL
subpopulation determinations. Our observations on repeated
studies in control subjects suggest that variation in T-
lymphocyte subsets is the rule rather than the exception.
Studies in ill subjects indicate that these changes are even more
pronounced [481. These individual variations over time have
also been reported for NK-cell activity in normal subjects [49].
We also investigated the lymphocyte subset defined by the
monclonal antibody Leu-7 which is believed to identify NK-
cells. NK-cells are so named because of their ability to mediate
cytolysis without prior sensitization. Although we found that
blood transfusion was associated with a decreased absolute
number of Leu-7 cells, we did not find any difference between
transfused and nontransfused individuals in the functional abil-
ity of their NK-cells to lyse radiolabelled K562 target cells. This
apparent discrepancy between changes in NK cell number and
function may be explained by the relative insensitivity of the
monoclonal antibody Leu-7 to identify NK cells. More recent
evidence suggests that the monoclonal antibody Leu-l1 may be
more specific for PBL with NK activity [50].
The possible role of NK cells in resistance to transplants has
been the subject of several investigations because the natural
resistance of mice to bone marrow transplants appears to be
correlated with the level of NK activity [51, 52]. While the
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uremic subjects in the present investigation had a marked
decrease in NK activity as compared to controls, other studies
have shown either depressed NK activity in hemodialyzed
subjects 1131 or normal NK activity [14, 16] with depression of
activity in renal allograft recipients [141. Whether or not de-
creased human NK activity is a significant factor enhancing
allograft survival in uremic individuals remains to be deter-
mined.
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